Current trends for investment in HIV prevention R&D by technology
Avac Event
PrEP That Booty: The latest on rectal microbicide research for the back door
Thursday, June 29 at 9:00 AM–10:30AM ET
Most of what we hear about regarding the HIV prevention pipeline is about long-acting, longer-acting, and even longer-acting products that deliver drug throughout the body and require a trained clinician to deliver. However, these attributes are not desirable to many folks, and communities want a range of choices. Researchers and advocates for years have been working on HIV prevention products specifically for the back door (rectum) to provide protection during anal intercourse. These products are user-controlled, non-systemic (the drug stays in the booty and only the booty), and are short-acting, so you don’t have to commit to having a prevention drug in your body for a year or longer. Join us for a dynamic discussion regarding the latest research on Booty PrEP – aka rectal microbicides – with our multi-talented panel.
Speakers include: Jonathan Baker, PA, Laser Surgery Care, Dr. Craig Hendrix, Johns Hopkins, Juan Michael Porter II, The Body, and Dr. Sharon Riddler, University of Pittsburgh
Avac Event
PrEP (In)equity: Documenting, measuring, and flipping the script towards justice
Tuesday, May 9 at 9:00 AM–10:30AM ET
Disparities in PrEP awareness, access, and uptake are stark in the United States, and play out along lines of race, gender, age, and geography. While we see increases in PrEP uptake overall, these metrics tend to mask the fact that the people who most need PrEP are not to be found in those numbers. As we see new modes of PrEP delivery become available, we are concerned these “shiny new things” will be yet another way to measure disparities and not actually help those who most need it. We must focus on these inequities with laser-like intensity, allocate resources using an equity model, and strive harder for PrEP justice.
Speakers include: Leisha-McKinley Beach, National HIV/AIDS Consultant, Michael Chancley, PrEP4All, and Dr. Patrick Sullivan, Emory
Avac Event
PrEP In Black America: New Orleans
PrEP is a tool to effectively prevent HIV, but despite FDA approval in 2012, only 9 percent of Black people who could benefit from PrEP have received it. To address dismal PrEP utilization rates in the Black community, Black HIV prevention advocates convened in Atlanta, GA for the first PrEP In Black America Summit. With community input from the summit, we published “For Us, By Us: PrEP In Black America: A Master Plan For HIV Prevention In Black America” which outlined key recommendations for stakeholders to implement to increase racial equity in PrEP uptake.
Join Black HIV prevention advocates from across the U.S. for the second interactive PrEP In Black America Summit in New Orleans, LA on May 19, as we develop and build on existing strategies to increase PrEP access and awareness in the Black community.
Thanks to sponsorship from Red Hot Organization, registration for the summit is FREE, including a lunch. Due to a limit of 200 attendees, please register once you have confirmed that you will be able to attend in person on May 19, 2023. We will also have a live, interactive virtual option to attend. For more information, visit prep4all.org/prepinblackamerica.
Avac Event
Biomedical Px Summit
The 2023 Biomedical HIV Prevention Summit is coming to Las Vegas, April 11 – 12. Now in it’s seventh year, the Summit’s continuing focus has been on the implementation of biomedical tools in our prevention and treatment efforts to ultimately end the HIV epidemic in communities. To make real impacts, it’s important to learn about and from different communities. This year’s Summit will lean into sex and pleasure. Since sex is the main way that HIV is transmitted, we need to focus on consensual sex in all of its iterations. We’ll talk about kink, fetishes, sex work, etc. in an open, honest, and frank way. After all, if we can’t talk about sex, how can we talk about HIV prevention?
The Summit will feature sessions on the need for a National PrEP program, community participation in research, sex positivity, insurance for PrEP and other topics. Make sure to visit the Abstracts tab for the full listing of tracks and track descriptions. The abstract submission deadline is February 6. Stay tuned for information about the general abstract webinar on January 19.
We’re expecting over 1,400 people to join us this year. Summit attendees include leaders, advocates, and educators all interested in sharing ideas and learning about new approaches to maximize the use of biomedical HIV prevention methods. Make sure you’re there to exhibit or provide support as a sponsor to engage with these groups. Visit the Exhibits and Sponsors tabs to get more information and reserve a spot.
“What happens in Vegas stays in Vegas.” This time, we want what happens in Vegas to influence HIV prevention all over the country.
Doxycycline for STI Prevention: Evidence and Current Research
Friday, October 7, 2022
Very high STI prevalence is being observed globally. Doxycycline post-exposure prophylaxis (dPEP) has been proposed as an STI prevention strategy to reduce chlamydia, syphilis, and possibly gonorrhea, and trials are ongoing among cisgender gay and bisexual men as well as African cisgender women. Learn about the latest scientific data and more during this Choice Agenda webinar.
Featuring Dr. Connie Celum, Jennifer Mahn, Dr. Victor Omollo, Rodney Perkins and Dr. Jenell Stewart
Picking Up the Pace
PrEP introduction is gaining traction around the world. Check out AVAC’s graphic showing global totals, and the uptick in implementation studies, regulatory approvals, global recommendations and more.
PrEP
PrEP works. Investment in more options must continue. Faster, smarter rollout must be a top priority.
Biomedical HIV Prevention Research in 2022 and Beyond
This report provides a concise update on the full landscape of biomedical interventions: including PrEP products in the market and next-gen products in the pipeline—multipurpose products (MPTs), vaccines and broadly neutralizing antibodies.
Correlations between Oral Pre-Exposure Prophylaxis (PrEP) Initiations and Policies that Enable the Use of PrEP to Address HIV Globally
This article from PLoS Global Public Health presents the results of an analysis examining whether policies enabling broad PrEP eligibility, HIV self-testing, and lowered age of consent to HIV testing and treatment services are correlated with PrEP uptake.